Quest Diagnostics (DGX) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $2.1 billion.
- Quest Diagnostics' Total Current Liabilities rose 200.76% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 200.76%. This contributed to the annual value of $2.2 billion for FY2024, which is 1950.41% up from last year.
- Latest data reveals that Quest Diagnostics reported Total Current Liabilities of $2.1 billion as of Q3 2025, which was up 200.76% from $2.0 billion recorded in Q2 2025.
- Quest Diagnostics' Total Current Liabilities' 5-year high stood at $2.3 billion during Q1 2024, with a 5-year trough of $1.4 billion in Q1 2023.
- Moreover, its 5-year median value for Total Current Liabilities was $1.8 billion (2021), whereas its average is $1.8 billion.
- In the last 5 years, Quest Diagnostics' Total Current Liabilities soared by 6959.41% in 2024 and then plummeted by 3729.33% in 2025.
- Quest Diagnostics' Total Current Liabilities (Quarter) stood at $1.8 billion in 2021, then decreased by 11.52% to $1.6 billion in 2022, then grew by 17.02% to $1.8 billion in 2023, then increased by 19.5% to $2.2 billion in 2024, then decreased by 1.61% to $2.1 billion in 2025.
- Its Total Current Liabilities was $2.1 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $1.4 billion in Q1 2025.